Stockscreener 앱 받기
2.15
7.73%
-0.18
시간 외 거래:
2.17
0.02
+0.93%
Acrivon Therapeutics Inc 주식 (ACRV) 가격 이력
일일
주별
월별
7일
30일
60일
YTD
1년
| 날짜 | 고가 | 저가 | 고가 - 저가 | 거래량 | % 변화 |
|---|---|---|---|---|---|
| 2025-11-04 | $2.30 | $2.11 | $0.19 | 1,194,708.0 | -7.73% |
| 2025-11-03 | $2.46 | $2.13 | $0.33 | 13,000,067.0 | +17.09% |
| 2025-10-31 | $2.01 | $1.94 | $0.0699 | 193,554.0 | +2.58% |
| 2025-10-30 | $1.97 | $1.88 | $0.09 | 206,374.0 | +2.65% |
| 2025-10-29 | $2.06 | $1.88 | $0.18 | 264,764.0 | -4.55% |
| 2025-10-28 | $2.17 | $1.96 | $0.215 | 543,622.0 | -5.26% |
| 2025-10-27 | $2.14 | $2.05 | $0.0893 | 315,146.0 | +0.97% |
| 2025-10-24 | $2.12 | $1.99 | $0.135 | 298,858.0 | +3.50% |
| 2025-10-23 | $2.06 | $1.92 | $0.145 | 348,842.0 | +0.50% |
| 2025-10-22 | $2.05 | $1.93 | $0.1177 | 402,537.0 | -2.45% |
| 2025-10-21 | $2.05 | $1.89 | $0.16 | 605,680.0 | +6.25% |
| 2025-10-20 | $1.95 | $1.83 | $0.12 | 233,509.0 | +6.08% |
| 2025-10-17 | $1.94 | $1.80 | $0.1399 | 214,689.0 | -3.21% |
| 2025-10-16 | $2.04 | $1.86 | $0.18 | 554,646.0 | -1.06% |
| 2025-10-15 | $1.92 | $1.75 | $0.17 | 322,837.0 | +8.62% |
| 2025-10-14 | $1.80 | $1.69 | $0.115 | 244,988.0 | -1.69% |
| 2025-10-13 | $1.90 | $1.71 | $0.19 | 576,401.0 | -3.28% |
| 2025-10-10 | $2.01 | $1.82 | $0.19 | 716,303.0 | -6.63% |
| 2025-10-09 | $2.02 | $1.87 | $0.15 | 434,830.0 | +4.26% |
| 2025-10-08 | $2.00 | $1.86 | $0.14 | 364,559.0 | -1.57% |
| 2025-10-07 | $1.96 | $1.82 | $0.14 | 710,504.0 | +0.00% |
Acrivon Therapeutics Inc 주식 (ACRV) 연도별 가격 이력
이 심층 분석에서는 Acrivon Therapeutics Inc 주식의 수년간 가격 움직임에 대한 포괄적인 개요를 제공합니다. 연도별 데이터를 살펴봄으로써 투자자들은 ACRV 주식의 과거 성과와 변동성에 대한 가치 있는 통찰력을 얻을 수 있습니다. 중요한 이정표와 변동부터 주목할만한 트렌드까지, 이 Acrivon Therapeutics Inc 주식 가격 이력에 대한 심층적인 분석은 회사의 주식이 시간이 흐름에 따라 어떻게 발전해왔는지 이해하는 데 기초를 제공합니다.
Acrivon Therapeutics Inc 주식 (ACRV) 가격 이력 2025
| 월 | 고가 | 저가 | 고가 - 저가 | 거래량 | % 변화 |
|---|---|---|---|---|---|
| 2025-11 | $2.46 | $2.11 | $0.35 | 15,389,483.0 | +8.04% |
| 2025-10 | $2.17 | $1.69 | $0.49 | 9,191,176.0 | +9.94% |
| 2025-09 | $2.67 | $1.30 | $1.37 | 65,831,207.0 | +35.07% |
| 2025-08 | $1.44 | $1.20 | $0.2348 | 3,796,173.0 | +4.69% |
| 2025-07 | $1.50 | $1.15 | $0.345 | 6,316,057.0 | +7.56% |
| 2025-06 | $1.41 | $1.05 | $0.36 | 10,293,267.0 | +13.33% |
| 2025-05 | $1.50 | $1.05 | $0.45 | 15,442,913.0 | -25.00% |
| 2025-04 | $2.19 | $1.30 | $0.89 | 24,369,680.0 | -31.03% |
| 2025-03 | $5.75 | $2.02 | $3.73 | 3,486,033.0 | -61.77% |
| 2025-02 | $8.00 | $4.69 | $3.31 | 1,549,969.0 | -12.52% |
| 2025-01 | $7.18 | $5.28 | $1.90 | 708,649.0 | +0.83% |
Acrivon Therapeutics Inc 주식 (ACRV) 가격 이력 2024
| 월 | 고가 | 저가 | 고가 - 저가 | 거래량 | % 변화 |
|---|---|---|---|---|---|
| 2024-12 | $7.82 | $5.40 | $2.42 | 1,258,567.0 | -28.63% |
| 2024-11 | $8.74 | $6.11 | $2.63 | 946,506.0 | -5.25% |
| 2024-10 | $8.46 | $6.85 | $1.61 | 1,561,460.0 | +14.29% |
| 2024-09 | $10.00 | $6.95 | $3.05 | 2,669,110.0 | -26.24% |
| 2024-08 | $10.16 | $6.87 | $3.29 | 1,336,977.0 | +13.25% |
| 2024-07 | $9.24 | $5.74 | $3.50 | 1,981,107.0 | +44.48% |
| 2024-06 | $8.15 | $5.50 | $2.65 | 2,381,138.0 | -24.87% |
| 2024-05 | $10.29 | $7.46 | $2.83 | 2,619,712.0 | -15.07% |
| 2024-04 | $11.90 | $5.70 | $6.20 | 44,580,956.0 | +27.13% |
| 2024-03 | $7.31 | $4.49 | $2.82 | 1,836,717.0 | +47.12% |
| 2024-02 | $5.46 | $3.19 | $2.27 | 1,710,559.0 | +33.15% |
| 2024-01 | $5.31 | $3.46 | $1.85 | 1,137,420.0 | -25.81% |
Acrivon Therapeutics Inc 주식 (ACRV) 가격 이력 2023
| 월 | 고가 | 저가 | 고가 - 저가 | 거래량 | % 변화 |
|---|---|---|---|---|---|
| 2023-12 | $6.36 | $4.09 | $2.27 | 796,430.0 | +21.48% |
| 2023-11 | $6.25 | $3.41 | $2.84 | 520,337.0 | -22.71% |
| 2023-10 | $9.40 | $4.96 | $4.44 | 493,948.0 | -45.19% |
| 2023-09 | $12.52 | $8.81 | $3.71 | 253,016.0 | -18.43% |
| 2023-08 | $12.89 | $10.59 | $2.30 | 252,222.0 | -5.79% |
| 2023-07 | $13.50 | $10.28 | $3.22 | 300,054.0 | -4.01% |
| 2023-06 | $14.03 | $11.50 | $2.53 | 873,760.0 | +10.02% |
| 2023-05 | $14.30 | $10.66 | $3.64 | 538,266.0 | -4.31% |
| 2023-04 | $12.94 | $8.06 | $4.88 | 571,246.0 | -2.99% |
| 2023-03 | $23.16 | $11.25 | $11.91 | 2,935,578.0 | +0.00% |
1.45%
0.86%
자본화:
|
볼륨(24시간):